288 related articles for article (PubMed ID: 27265454)
1. Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine.
Best EJ; Walls T; Souter M; Neeff M; Anderson T; Salkeld L; Ahmad Z; Mahadevan M; Walker C; Murdoch D; Mills N
Vaccine; 2016 Jul; 34(33):3840-7. PubMed ID: 27265454
[TBL] [Abstract][Full Text] [Related]
2. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.
Mills N; Best EJ; Murdoch D; Souter M; Neeff M; Anderson T; Salkeld L; Ahmad Z; Mahadevan M; Barber C; Brown C; Walker C; Walls T
J Paediatr Child Health; 2015 Mar; 51(3):300-6. PubMed ID: 25175818
[TBL] [Abstract][Full Text] [Related]
3. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
[TBL] [Abstract][Full Text] [Related]
4. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
[TBL] [Abstract][Full Text] [Related]
5. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
Casey JR; Adlowitz DG; Pichichero ME
Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
[TBL] [Abstract][Full Text] [Related]
6. Otopathogens in the middle ear and nasopharynx of children with recurrent acute otitis media.
Ruttkay Pereira DR; Pereira MR; Rotta Pereira MB; Costa SS; Mott MP; Cantarelli V
Int J Pediatr Otorhinolaryngol; 2023 Jun; 169():111552. PubMed ID: 37120991
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial.
Beissbarth J; Wilson N; Arrowsmith B; Binks MJ; Oguoma VM; Lawrence K; Llewellyn A; Mulholland EK; Santosham M; Morris PS; Smith-Vaughan HC; Cheng AC; Leach AJ
Vaccine; 2021 Apr; 39(16):2264-2273. PubMed ID: 33766422
[TBL] [Abstract][Full Text] [Related]
8. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan.
Hoshino T; Takeuchi N; Fukasawa C; Hirose S; Okui H; Sato H; Sato M; Arimoto Y; Nakano A; Ishiwada N
J Infect Chemother; 2017 Feb; 23(2):85-89. PubMed ID: 27889249
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.
Bosch AATM; van Houten MA; Bruin JP; Wijmenga-Monsuur AJ; Trzciński K; Bogaert D; Rots NY; Sanders EAM
Vaccine; 2016 Jan; 34(4):531-539. PubMed ID: 26667610
[TBL] [Abstract][Full Text] [Related]
11. Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children.
Abdelnour A; Arguedas A; Dagan R; Soley C; Porat N; Mercedes Castrejon M; Ortega-Barria E; Colindres R; Pirçon JY; DeAntonio R; Van Dyke MK
Medicine (Baltimore); 2015 Jan; 94(2):e320. PubMed ID: 25590837
[TBL] [Abstract][Full Text] [Related]
12. 10-Valent pneumococcal non-typeable
Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis J; Krause V; Andrews R; Snelling T; Licciardi P; Morris P; Leach AJ
BMJ Open; 2020 May; 10(5):e033511. PubMed ID: 32448790
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.
Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Chatfield MD; Lehmann D; Binks M; Chang AB; Carapetis J; Krause V; Andrews R; Snelling T; Skull SA; Licciardi PV; Oguoma VM; Morris PS
Lancet Infect Dis; 2022 Sep; 22(9):1374-1387. PubMed ID: 35772449
[TBL] [Abstract][Full Text] [Related]
14. The microbiome of otitis media with effusion in Indigenous Australian children.
Jervis-Bardy J; Rogers GB; Morris PS; Smith-Vaughan HC; Nosworthy E; Leong LE; Smith RJ; Weyrich LS; De Haan J; Carney AS; Leach AJ; O'Leary S; Marsh RL
Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1548-55. PubMed ID: 26228497
[TBL] [Abstract][Full Text] [Related]
15. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan.
Oikawa J; Ishiwada N; Takahashi Y; Hishiki H; Nagasawa K; Takahashi S; Watanabe M; Chang B; Kohno Y
J Infect Chemother; 2014 Feb; 20(2):146-9. PubMed ID: 24582389
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of nasopharyngeal culture in identification of pathogen in middle ear fluid in chronic otitis media with effusion.
Eser OK; Ipci K; Alp S; Akyol U; Unal OF; Hascelik G; Sennaroglu L; Gür D
Indian J Med Microbiol; 2009; 27(3):237-41. PubMed ID: 19584505
[TBL] [Abstract][Full Text] [Related]
17. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial.
van Gils EJ; Veenhoven RH; Rodenburg GD; Hak E; Sanders EA
Vaccine; 2011 Oct; 29(44):7595-8. PubMed ID: 21893151
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
[TBL] [Abstract][Full Text] [Related]
19. Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.
Camilli R; Vescio MF; Giufrè M; Daprai L; Garlaschi ML; Cerquetti M; Pantosti A
Vaccine; 2015 Aug; 33(36):4559-64. PubMed ID: 26190092
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
Allemann A; Frey PM; Brugger SD; Hilty M
Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
